Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Hanover Media Strategy Limited naming Pádraig O'Sullivan .
Filed returns
25
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Hanover Media Strategy Limited | Sports and Recreation | Targeted correspondence, meetings and an event in Leinster House with Oireachtas members concerning the Federation of Irish Sport’s Budget 2027 proposals (Public policy or programme) | 13 | On lobbying.ie |
| Sep–Dec 2025 | Hanover Media Strategy Limited | Health | AV Room Briefing Event to discuss a Proposal for an Early Access Programme for Innovative Oncology Medicines (Public policy or programme) | 41 | On lobbying.ie |
| Sep–Dec 2025 | Hanover Media Strategy Limited | Sports and Recreation | Meeting request to discuss the Federation of Irish Sport's Pre Budget Submission (Public policy or programme) | 28 | On lobbying.ie |
| Sep–Dec 2025 | Hanover Media Strategy Limited | Health | Meeting request to discuss protection for over 65s in winter flu season (Public policy or programme) | 33 | On lobbying.ie |
| May–Aug 2025 | Hanover Media Strategy Limited | Sports and Recreation | AV Room Briefing Event to discuss the ongoing policy challenges in the sports sector (Public policy or programme) | 62 | On lobbying.ie |
| May–Aug 2025 | Hanover Media Strategy Limited | Health | Meeting request to discuss protection for over 65s in winter flu season (Public policy or programme) | 19 | On lobbying.ie |
| Jan–Apr 2025 | Hanover Media Strategy Limited | Health | Rare Disease & Life Sciences Policy (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2025 | Hanover Media Strategy Limited | Energy and Natural Resources | Meeting request from the Alliance for Zero Carbon Heating (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Hanover Media Strategy Limited | Health | AstraZeneca health policy priorities for the new Programme for Government (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2024 | Hanover Media Strategy Limited | Health | Life Sciences Strategy for Ireland (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2024 | Hanover Media Strategy Limited | Health | To share information on the level of vaccine protection for the over 65s population in Ireland (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2024 | Hanover Media Strategy Limited | Health | Health priorities for the Programme for Government (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2024 | Hanover Media Strategy Limited | Health | Invite to Leinster House briefing on the burden of influenza in Ireland (Public policy or programme) | 15 | On lobbying.ie |
| May–Aug 2024 | Hanover Media Strategy Limited | Health | Meeting request on the level of influenza vaccine protection for the over 65 population in Ireland. (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2024 | Hanover Media Strategy Limited | Health | Engagement with members of the health committee in advance of debate on rare diseases (Public policy or programme) | 15 | On lobbying.ie |
| May–Aug 2023 | Hanover Media Strategy Limited | Health | Discussion on the level of influenza vaccine protection for the over 65 population in Ireland. (Public policy or programme) | 23 | On lobbying.ie |
| Jan–Apr 2023 | Hanover Media Strategy Limited | Health | Rare Disease Policy (Legislation) | 17 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Health | Rare Disease Policy (Legislation) | 9 | On lobbying.ie |
| Sep–Dec 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 4 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 9 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 15 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 9 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 14 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 16 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 21 | 84.0% | |
| Sports and Recreation | 3 | 12.0% | |
| Energy and Natural Resources | 1 | 4.0% |